BridgeBio logo

BridgeBio Employee Directory

Biotechnology ResearchCalifornia, United States1001-5000 Employees

BridgeBio is a biotechnology research company headquartered in Palo Alto, California, United States, with 501-1000 employees. It focuses on developing therapies for genetic conditions, aiming to translate advances in genetic science into real-world patient impact. The company is active in drug development within the biotechnology research sector. In 2026, BridgeBio submitted an NDA to the FDA for encaleret to treat ADH1, and the FDA accepted an NDA for BBP-418 for LGMD2I/R9 with priority review. Public disclosures indicate ongoing regulatory activity and investor coverage related to its programs.

Find BridgeBio employees' phone numbers or email addresses

BridgeBio Global Highlights

Location
Employees

North America
930

Minus sign iconPlus sign icon
  • United States Of America
    929
  • Canada
    1

Europe
50

Minus sign iconPlus sign icon
  • Switzerland
    27
  • Netherlands
    9
  • United Kingdom Of Great Britain And Northern Ireland
    4
  • France
    4
  • Germany
    3
  • Slovenia
    1
  • Croatia
    1
  • Sweden
    1

Asia
12

Minus sign iconPlus sign icon
  • China
    8
  • India
    2
  • Indonesia
    1
  • Pakistan
    1

Africa
2

Minus sign iconPlus sign icon
  • Ghana
    1
  • Kenya
    1

Oceania
1

Minus sign iconPlus sign icon
  • Australia
    1

South America
1

Minus sign iconPlus sign icon
  • Argentina
    1

BridgeBio's Leadership

  • Ceo And Founder at BridgeBio
    N. K.
    Ceo And Founder
  • Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio at BridgeBio
    M. O.
    Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio
  • Chief Regulatory Affairs Officer & Evp Portfolio Strategy And Management at BridgeBio
    A. N.
    Chief Regulatory Affairs Officer & Evp Portfolio Strategy And Management
  • Chief Operating Officer, Cardiovascular at BridgeBio
    J. L.
    Chief Operating Officer, Cardiovascular
  • Chief Development Officer, Cardiovascular at BridgeBio
    L. K.
    Chief Development Officer, Cardiovascular
  • Chief Accounting Officer at BridgeBio
    A. R.
    Chief Accounting Officer
  • Chief Technical Officer at BridgeBio
    A. T.
    Chief Technical Officer
  • Vp & General Manager, Partner Markets at BridgeBio
    S. W.
    Vp & General Manager, Partner Markets

BridgeBio Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Operations
  • Engineering
  • Finance
  • Program & Project Management
  • Other
  • Sales
  • Biotechnology
  • Legal
  • Administrative
  • Business
  • Quality Assurance
  • Pharmaceuticals

Contact profiles from BridgeBio

Name
Title
Contact
Location
Last Update
  • Ceo And Founder at BridgeBio
    N. K.
    Ceo And Founder
    Bay
    May 03, 2026
  • Chief Regulatory Affairs Officer & Evp Portfolio Strategy And Management at BridgeBio
    A. N.
    Chief Regulatory Affairs Officer & Evp Portfolio Strategy And Management
    Sep 20, 2026
  • Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio at BridgeBio
    M. O.
    Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio
    Bay
    Oct 16, 2026
  • Chief Operating Officer, Cardiovascular at BridgeBio
    J. L.
    Chief Operating Officer, Cardiovascular
    Bay
    Sep 23, 2026
  • Chief Development Officer, Cardiovascular at BridgeBio
    L. K.
    Chief Development Officer, Cardiovascular
    Bay
    Sep 16, 2026
  • Senior Manager, Small Molecule Drug Substance, Cmo at BridgeBio
    O. W.
    Senior Manager, Small Molecule Drug Substance, Cmo
    Croatia
    Oct 07, 2026
  • Chief Accounting Officer at BridgeBio
    A. R.
    Chief Accounting Officer
    Oct 21, 2024
  • President at BridgeBio
    A. B.
    President
    Oct 23, 2024
  • Chief Technical Officer at BridgeBio
    A. T.
    Chief Technical Officer
    Oct 21, 2024
  • Executive Vice President at BridgeBio
    B. M.
    Executive Vice President
    Bay
    Sep 01, 2026

Frequently Asked Questions

What is BridgeBio known for?

Minus sign iconPlus sign icon
BridgeBio was founded in 2014 and operates in the Biotechnology Research industry. Explore BridgeBio's company overview page for more information.

What is BridgeBio's most common email format?

Minus sign iconPlus sign icon
BridgeBio employees' email format typically follows the pattern of First.Last@bridgebio.com. Trying to find reliable and up-to-date employee contact data? Find more BridgeBio email formats with LeadIQ.

How many employees does BridgeBio have currently?

Minus sign iconPlus sign icon
BridgeBio has approximately 1.1K employees as of October 2026. These team members are located across 6 continents, including North America, Europe and Asia.

Who are BridgeBio's key employees and leadership?

Minus sign iconPlus sign icon

As of October 2026, BridgeBio's key employees include:

  • Ceo And Founder: N. K.
  • Chief Executive Officer At Qed Therapeutics Oncology And Chief Commercial Officer At Bridgebio: M. O.
  • Chief Regulatory Affairs Officer & Evp Portfolio Strategy And Management: A. N.
  • Chief Operating Officer, Cardiovascular: J. L.
  • Chief Development Officer, Cardiovascular: L. K.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.